Clinical trials: Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Relapsing Forms of Multiple Sclerosis
Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis
This is an observational cross-sectional study of Ocrelizumab or Ofatumumab administrations for Relapsing forms of Multiple Sclerosis (RMS) in selected sites in the US, the UK and Australia.
- Trial name
- TIMIOS (NCT04676555)
- Testing
- Ocrelizumab, Ofatumumab
- Where
- 2 sites in United States, Australia
- Volunteers
- 2 people
- Sponsor
- Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
This study will assess tolerability and safety and health outcomes in relapsing MS patients taking FTY720.
- Trial name
- NCT01127750
- Testing
- FTY720
- Where
- 289 sites in Australia, Austria and 21 more
- Volunteers
- 2,417 people
- Sponsor
- Novartis